KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to 32.11%.

  • Idexx Laboratories' EBITDA Margin rose 9500.0% to 32.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.34%, marking a year-over-year increase of 24200.0%. This contributed to the annual value of 28.95% for FY2024, which is 10200.0% down from last year.
  • Per Idexx Laboratories' latest filing, its EBITDA Margin stood at 32.11% for Q3 2025, which was up 9500.0% from 33.62% recorded in Q2 2025.
  • Idexx Laboratories' EBITDA Margin's 5-year high stood at 33.62% during Q2 2025, with a 5-year trough of 20.81% in Q2 2022.
  • For the 5-year period, Idexx Laboratories' EBITDA Margin averaged around 29.26%, with its median value being 30.07% (2023).
  • Its EBITDA Margin has fluctuated over the past 5 years, first tumbled by -105700bps in 2022, then surged by 105800bps in 2023.
  • Idexx Laboratories' EBITDA Margin (Quarter) stood at 24.86% in 2021, then increased by 10bps to 27.34% in 2022, then decreased by 0bps to 27.21% in 2023, then rose by 1bps to 27.42% in 2024, then rose by 17bps to 32.11% in 2025.
  • Its EBITDA Margin was 32.11% in Q3 2025, compared to 33.62% in Q2 2025 and 31.7% in Q1 2025.